CME
Part 2: Improving Risk-based Management Decisions in Follicular Lymphoma
November 24, 2020
Host: Timothy Fenske, MD, MS
The anti-CD20 antibody rituximab has been the backbone of initial treatment for previously untreated follicular lymphoma (FL). The treatment options for FL are expanding, with multiple novel agents now approved by the US
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!